Isofol Medical AB Cash Flow-to-Debt Ratio
Isofol Medical AB cash flow-to-debt ratio. Isofol Medical AB (ISOFOL) has a Cash Flow-to-Debt Ratio of -0.50x as of September 2025, meaning its operating cash flow of Skr-10.78 Million could theoretically repay -1% of its total liabilities (Skr21.51 Million) in one year. See Isofol Medical AB leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Isofol Medical AB (2015–2025)
Cash flow-to-debt ratio of Isofol Medical AB from 2015 to 2025. Historical debt coverage capacity for Isofol Medical AB across 11 annual periods. Also explore ISOFOL year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Isofol Medical AB Cash Flow-to-Debt Ratio by Year (2015–2025)
Isofol Medical AB cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Isofol Medical AB. For the full cash flow conversion analysis, see Isofol Medical AB cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.41x | Skr-51.94 Million | Skr21.52 Million | ▼ -17.6% |
| 2024 | -2.05x | Skr-41.99 Million | Skr20.47 Million | ▲ +25.2% |
| 2023 | -2.74x | Skr-52.54 Million | Skr19.16 Million | ▲ +21.1% |
| 2022 | -3.47x | Skr-190.97 Million | Skr54.99 Million | ▼ -53.2% |
| 2021 | -2.27x | Skr-188.43 Million | Skr83.13 Million | ▼ -15.4% |
| 2020 | -1.96x | Skr-160.27 Million | Skr81.56 Million | ▲ +44.5% |
| 2019 | -3.54x | Skr-147.21 Million | Skr41.56 Million | ▲ +9.8% |
| 2018 | -3.93x | Skr-92.46 Million | Skr23.54 Million | ▼ -15.7% |
| 2017 | -3.40x | Skr-61.94 Million | Skr18.24 Million | ▼ -0.2% |
| 2016 | -3.39x | Skr-56.90 Million | Skr16.79 Million | ▲ +22.1% |
| 2015 | -4.35x | Skr-36.77 Million | Skr8.46 Million | — |